Literature DB >> 171694

Electroencephalographic studies on the development of tolerance and cross tolerance to mescaline in the rat.

B Colasanti, N Khazan.   

Abstract

Recordings of the electroencephalogram (EEG) and the electromyogram (EMG) were collected continuously from rats equipped with permanent cortical and temporalis muscle electrodes. Automatic injections of mescaline were administered through indwelling i.p. cannulas at an initial dose of 30 mg/kg every 6 hrs for the first 2 days. This dose was then increased to 60 mg/kg 6 hr which was given for the duration of the study. The initial injections of the mescaline induced an immediate desynchronization of the EEG and behavioral arousal of the rat, which endured for 2-3 hrs. After this time, slow wave (SW) sleep and rapid eye movement (REM) sleep episodes reappeared, with the return of regular alternations of the sleep-wakefulness cycle. Upon continued administration of the drug, partial tolerance to the arousal effects of mescaline developed, which was reflected by a gradual reduction in the latencies to onset of SW sleep and REM sleep. Rats rendered tolerant to mescaline in this manner were found to be cross tolerant to lysergic acid diethylamide (LSD) and N,N-diethyl-tryptamine (DET). In contrast, cross tolerance did not occur to amphetamine, which exerts similar arousal and EEG desynchronizing effects. These results agree with physiological and behavioral studies of tolerance and cross tolerance among hallucinogens and support the usefulness of the EEG as a quantitative indicator of central nervous system function.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171694     DOI: 10.1007/bf00429251

Source DB:  PubMed          Journal:  Psychopharmacologia


  21 in total

1.  Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.

Authors:  A B WOLBACH; H ISBELL; E J MINER
Journal:  Psychopharmacologia       Date:  1962-03-12

2.  Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.

Authors:  W R ADEY; F R BELL; B J DENNIS
Journal:  Neurology       Date:  1962-09       Impact factor: 9.910

3.  Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.

Authors:  D X FREEDMAN; G K AGHAJANIAN; E M ORNITZ
Journal:  Science       Date:  1958-05-16       Impact factor: 47.728

4.  Effects of mescaline and lysergic acid (d-LSD-25).

Authors:  P H HOCH; J P CATTELL; H H PENNES
Journal:  Am J Psychiatry       Date:  1952-02       Impact factor: 18.112

Review 5.  Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Authors:  H Kalant; A E LeBlanc; R J Gibbins
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

6.  Failure of N,N-dimethyltryptamine to evoke tolerance in cats.

Authors:  J C Gillin; E Cannon; R Magyar; M Schwartz; R J Wyatt
Journal:  Biol Psychiatry       Date:  1973-12       Impact factor: 13.382

7.  Mescaline: no tolerance to excitatory effects.

Authors:  W H Bridger; I J Mandel; D M Stoff
Journal:  Biol Psychiatry       Date:  1973-10       Impact factor: 13.382

8.  Cross tolerance to tryptamine in the LSD tolerant dog.

Authors:  W R Martin; C G Eades
Journal:  Psychopharmacologia       Date:  1972

9.  Tolerance and cross-tolerance among psychotomimetic drugs.

Authors:  J B Appel; D X Freedman
Journal:  Psychopharmacologia       Date:  1968-09-20

10.  The effect of mescaline upon the conditioned avoidance response in the rat.

Authors:  J R Smythies; E A Sykes
Journal:  Psychopharmacologia       Date:  1964-09-11
View more
  4 in total

1.  Effects of mescaline and amphetamine on simultaneous visual discrimination in two inbred strains of mice.

Authors:  C Castellano
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

Review 2.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

3.  The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.

Authors:  Daniela Dudysová; Karolina Janků; Michal Šmotek; Elizaveta Saifutdinova; Jana Kopřivová; Jitka Bušková; Bryce Anthony Mander; Martin Brunovský; Peter Zach; Jakub Korčák; Veronika Andrashko; Michaela Viktorinová; Filip Tylš; Anna Bravermanová; Tom Froese; Tomáš Páleníček; Jiří Horáček
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

4.  Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.

Authors:  Christopher W Thomas; Cristina Blanco-Duque; Benjamin J Bréant; Guy M Goodwin; Trevor Sharp; David M Bannerman; Vladyslav V Vyazovskiy
Journal:  Transl Psychiatry       Date:  2022-02-23       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.